Pulmonary vascular resistance predicts early mortality in patients with diffuse fibrotic lung disease and suspected pulmonary hypertension

Thorax

Volumn 64, Issue 10, 2009, Pages 883-888

  Corte, T J ^a,b   Wort, S J ^a   Gatzoulis, M A ^a   Macdonald, P ^b   Hansell, D M ^a   Wells, A U ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FIBROSING ALVEOLITIS; HEART CATHETERIZATION; HUMAN; LUNG ARTERY PRESSURE; LUNG FIBROSIS; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 70349673627     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2008.112847     Document Type: Article

References (46)

1. Behr J, Ryu JH. Pulmonary hypertension in interstitial lung disease. Eur Respir J 2008;31:1357-1367
2. Nadrous HF, Pellikka PA, Krowka MJ, et al. The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis. Chest 2005;128(6 Suppl):616-7S.
3. Hamada K, Nagai S, Tanaka S, et al. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007;131:650-656 (Pubitemid 46446853)
4. Lettieri CJ, Nathan SD, Barnett SD, et al. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006;129:746-752
5. Nadrous HF, Pellikka PA, Krowka MJ, et al. Pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chest 2005;128:2393-2399 (Pubitemid 41507585)
6. Shorr AF, Wainright JL, Cors CS, et al. Pulmonary hypertension in patients with pulmonary fibrosis awaiting lung transplant. Eur Respir J 2007;30:715-721 (Pubitemid 351194832)
7. Agarwal R, Gupta D, Verma JS, et al. Noninvasive estimation of clinically asymptomatic pulmonary hypertension in idiopathic pulmonary fibrosis. Indian J Chest Dis Allied Sci 2005;47:267-271
8. Nathan SD, Shlobin OA, Ahmad S, et al. Serial development of pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Respiration 2008;76:288-294
9. Shorr AF, Helman DL, Davies DB, et al. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J 2005;25:783-788
10. Egan TM, Murray S, Bustami RT, et al. Development of the new lung allocation system in the United States. Am J Transplant 2006;6(5 Pt 2):1212-1227
11. Selimovic N, Andersson B, Bergh CH, et al. Pulmonary hemodynamics as predictors of mortality in patients awaiting lung transplantation. Transplant Int 2008;21:314-319 (Pubitemid 351348005)
12. American Thoracic Society/European Respiratory Society. Idiopathic pulmonary fibrosis: diagnosis and treatment; international consensus statement. Am J Respir Crit Care Med 2000;161:646-664
13. Cholley BP, Payen D. Noninvasive techniques for measurements of cardiac output. Curr Opin Crit Care 2005;11:424-429 (Pubitemid 41482697)
14. Mazza E, Taichman D. Functions and control of the pulmonary circulation. In: Taichman D, Mandel J, eds. Pulmonary vascular disease. 1st ed. Philadelphia: Elsevier, 2006:1-19.
15. Galie N, Torbicki A, Barst R, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 2004;25:2243-2278
16. Nathan SD, Shlobin OA, Barnett SD, et al. Right ventricular systolic pressure by echocardiography as a predictor of pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Med 2008;102:1305-1310
17. Arcasoy SM, Christie JD, Ferrari VA, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003;167:735-740 (Pubitemid 36801751)
18. Rich S. Executive summary from the World Symposium on Primary Pulmonary Hypertension. Evian, France: co-sponsored by the World Health Organization, 1998.
19. Raghu G, Brown KK, Bradford WZ, et al. A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004;350:125-133 (Pubitemid 38056223)
20. Nathan SD, Shlobin OA, Ahmad S, et al. Pulmonary hypertension and pulmonary function testing in idiopathic pulmonary fibrosis. Chest 2007;131:657-663 (Pubitemid 46446854)
21. Mogulkoc N, Brutsche MH, Bishop PW, et al. Pulmonary function in idiopathic pulmonary fibrosis and referral for lung transplantation. Am J Respir Crit Care Med 2001;164:103-108 (Pubitemid 33151306)
22. Jezek V, Fucik J, Michaljanic A, et al. The prognostic significance of functional tests in cryptogenic fibrosing alveolitis. Bull Eur Physiopathol Respir 1980;16:711-720
23. Martinez FJ, Safrin S, Weycker D, et al. The clinical course of patients with idiopathic pulmonary fibrosis. Ann Intern Med 2005;142(12 Pt 1):963-967 (Pubitemid 40840310)
24. Domiciliary Oxygen Therapy Services. Clinical guidelines and advice for prescribers. A report of the Royal College of Physicians. London: Royal College of Physicians, 1999.
25. Keller CA, Shepard JW Jr, Chun DS, et al. Pulmonary hypertension in chronic obstructive pulmonary disease. Multivariate analysis. Chest 1986;90:185-192
26. Letsou GV, Franco KL, Kopf GS, et al. Heart-lung transplantation: initial experience in New England. Conn Med 1990;54:419-424 (Pubitemid 20287921)
27. Latsi PI, du Bois RM, Nicholson AG, et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003;168:531-537
28. Perez-Padilla R, Salas J, Chapela R, et al. Mortality in Mexican patients with chronic pigeon breeder's lung compared with those with usual interstitial pneumonia. Am Rev Respir Dis 1993;148:49-53. (Pubitemid 23187216)
29. Feltrim MI, Rozanski A, Borges AC, et al. The quality of life of patients on the lung transplantation waiting list. Transplant Proc 2008;40:819-821 (Pubitemid 351608639)
30. Tuppin MP, Paratz JD, Chang AT, et al. Predictive utility of the 6-minute walk distance on survival in patients awaiting lung transplantation. J Heart Lung Transplant 2008;27:729-734
31. Martinu T, Babyak MA, O'Connell CF, et al. Baseline 6-min walk distance predicts survival in lung transplant candidates. Am J Transplant 2008;8:1498-1505 (Pubitemid 351989491)
32. Shitrit D, Gershman Y, Peled N, et al. Risk factors for death while awaiting lung transplantation in Israeli patients: 1997-2006. Eur J Cardiothorac Surg 2008;34:444-448
33. Perez-Enguix D, Morales P, Tomas JM, et al. Computed tomographic screening of pulmonary arterial hypertension in candidates for lung transplantation. Transplant Proc 2007;39:2405-2408 (Pubitemid 47418205)
34. Leuchte HH, Baumgartner RA, Nounou ME, et al. Brain natriuretic peptide is a prognostic parameter in chronic lung disease. Am J Respir Crit Care Med 2006;173:744-750
35. Sitbon O, Humbert M, Nunes H, et al. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002;40:780-788 (Pubitemid 34925627)
36. Paciocco G, Martinez FJ, Bossone E, et al. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J 2001;17:647-652 (Pubitemid 32492552)
37. Chemla D, Castelain V, Herve P, et al. Haemodynamic evaluation of pulmonary hypertension. Eur Respir J 2002;20:1314-1331
38. Leach RM, Treacher DF. Clinical aspects of hypoxic pulmonary vasoconstriction. Exp Physiol 1995;80:865-875
39. Zisman DA, Karlamangla AS, Ross DJ, et al. High-resolution chest computed tomography findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 2007;132:773-779
40. Devaraj A, Wells AU, Meister MG, et al. The effect of diffuse pulmonary fibrosis on the reliability of CT signs of pulmonary hypertension. Radiology 2008;249:1042-1049
41. van Wolferen SA, Marcus JT, Boonstra A, et al. Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension. Eur Heart J 2007;28:1250-1257
42. Jegal Y, Kim DS, Shim TS, et al. Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005;171:639-644 (Pubitemid 40365421)
43. Zisman DA, Ross DJ, Belperio JA, et al. Prediction of pulmonary hypertension in idiopathic pulmonary fibrosis. Respir Med 2007;101:2153-2159 (Pubitemid 47324243)
44. Zisman DA, Karlamangla AS, Kawut SM, et al. Validation of a method to screen for pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 2008;133:640-645
45. Flaherty KR, Andrei AC, Murray S, et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med 2006;174:803-809 (Pubitemid 44511662)
46. Lama VN, Flaherty KR, Toews GB, et al. Prognostic value of desaturation during a 6- minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003;168:1084-1090 (Pubitemid 37338937)